Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE Vernova Inc (GEV) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

GE Vernova IncTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

GE Vernova Inc vs Neurocrine Biosciences Inc — how do they compare? GE Vernova Inc trades at $1,026 (market cap $269.50B), while Neurocrine Biosciences Inc trades at $155.01 (market cap $16.46B). The key difference: GE Vernova Inc is far larger — about 16.4× Neurocrine Biosciences Inc's market cap, and GE Vernova Inc pays a 0.2% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

GEVNBIX
Market Cap
$269.50B$16.46B
Sector
TechnologyHealth
52-Week High
$1.17K$185.50
52-Week Low
$547.96$123.10
Enterprise Value
$259.17B$16.48B
Dividend Yield
0.2%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX